Adjuvants of Immunity
Open Access
- 4 March 2002
- journal article
- editorial
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 195 (5) , F19-F23
- https://doi.org/10.1084/jem.20020073
Abstract
Since Jules Freund reported that crude mycobacterial extracts greatly promoted immune responses to antigens ([1][1]), the use of adjuvants has become a widespread, but poorly understood practice to promote T and B cell responses ([2][2]). Recent studies have begun to identify the chemical nature ofKeywords
This publication has 43 references indexed in Scilit:
- Natural Killer T Cell Ligand α-Galactosylceramide Enhances Protective Immunity Induced by Malaria VaccinesThe Journal of Experimental Medicine, 2002
- Drosophila Toll is activated by Gram-positive bacteria through a circulating peptidoglycan recognition proteinNature, 2001
- Autoreactivity by design: innate B and T lymphocytesNature Reviews Immunology, 2001
- Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-κB pathwayInternational Immunology, 2000
- Selective induction of NK cell proliferation and cytotoxicity by activated NKT cellsEuropean Journal of Immunology, 2000
- Consequences of Cell DeathThe Journal of Experimental Medicine, 2000
- CD1d-Restricted and TCR-Mediated Activation of V α 14 NKT Cells by GlycosylceramidesScience, 1997
- Women Fight Uphill Battle for EquityScience, 1996
- The Instructive Role of Innate Immunity in the Acquired Immune ResponseScience, 1996
- C3d of Complement as a Molecular Adjuvant: Bridging Innate and Acquired ImmunityScience, 1996